SAPIEN M3 EFS: Early Feasibility Study of the Edwards SAPIEN M3 System for the Treatment of Mitral Regurgitation
NCT03230747
Cardiovascular Diseases, Disease
Los Angeles, California, United States
View Trial DetailsNCT Number: NCT01617720
This Study is designed to observe the clinical outcomes of patients requiring mitral repair that were treated with the CE certified Cardinal System.
Looking for future studies?
Notify Me18 year–85 year
All sexes
Observational
SANA Herzchirurgie, Stuttgart, Germany
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 30 day
Time frame: 6 months
Time frame: 6 months
The ability of the surgeon to adjust the Cardinal ring when required, will be measured on a scale of 1-3 (1- successfull, 3- unsuccessful)
Time frame: 6 months
Looking for future studies?
Notify MeEdwards Lifesciences
Industry
MITRAFIT Cardinal Adjustable Mitral Repair Follow-up International Postmarketing Surveillance (PMS)
Acronym: MITRAFIT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03230747
Cardiovascular Diseases, Disease
Los Angeles, California, United States
View Trial DetailsNCT06675448
Cardiovascular Diseases, Heart Diseases
Falls Church, Virginia, United States
View Trial DetailsNCT06539416
Cardiovascular Diseases, Heart Diseases
Třinec, CZ, Czechia
View Trial DetailsNCT04960280
Cardiovascular Diseases, Heart Diseases
Rochester, Minnesota, United States
View Trial Details